Addiction Medicine Updates

Videos

UPDATES

OPIOIDS

SBIRT

TRAINING EVENTS

Latest News & Upcoming Events

North Carolina Statewide Overdose Surveillance Reports

North Carolina Statewide Overdose Surveillance Reports

Learn more about overdoses in North Carolina with the resources available through the Injury and Violence Prevention Branch of the Division of Public Health. The Statewide Overdose Surveillance Reports provide annual or monthly statewide summaries plus county specific...

No Shortcuts to Safer Opioid Prescribing

No Shortcuts to Safer Opioid Prescribing

In a New England Journal of Medicine article, authors Deborah Dowell, MD, MPH, Tamara Haegerich, PhD., and Roger Chou, MD discuss the Guideline for Prescribing Opioids for Chronic Pain released by the Centers for Disease Control and Prevention (CDC) 2016,1 Medical and...

Apr
22
Mon
Waiver Training Online PCSS Office-Based Treatment for Opioid Use Disorders Webinar @ Live Webcast
Apr 22 @ 5:00 pm – 9:15 pm

As of the requirements to obtain the waiver, physicians without specified experience must complete not less than 8 hours of training. A total of 8 hours of training is federally mandated for physicians and a total of 24 hours of training is mandated for NPs and PAs.

The first half of the training is a 4.25-hour live webcast. The second half of the course is a 3.75-hour computer-based study. An examination on the computer study must be successfully completed within 30 days of the webinar session as part of the process to obtain a waiver for prescribing buprenorphine. 

Instructions on how to log on to the second half of the course will be provided via email, ONLY to those who complete the 4.25-hour live webcast in its entirety. Please note that in order to be eligible for the waiver to prescribe Buprenorphine, you must complete a total of 8 hours consisting of the live webcast session (4.25-hours) and the online self-study session and exam (3.75-hours) within 30 days of the live webcast session. The AOAAM cannot verify completion of the webinar session if less than 4.25 hours are attended. Should you not attend for the entire session, you will have to retake the entire webinar again on a different date in order to get credit. Please be aware that it is MANDATORY that you are able to view and hear the presentation and participate in the interactive polling questions in order for the AOAAM to verify your attendance. The combined live webcast and online self-study training will provide the required 8 hours needed to obtain the waiver to prescribe buprenorphine in office-based treatment of opioid dependence. Physicians who complete this course will meet the training qualification under the new law. For NPs and PAs, an additional 16-hours of training will be required for waiver eligibility.

CONTINUING MEDICAL EDUCATION: This program has been approved for 4.25 AOA Category 1-A CME credits (live webcast session only) providing all requirements have been met. It has also been approved for 4.25 AAFP Prescribed Credit hours, which are eligible for the AMA’s Physician Recognition Award Credit. Participants are required to attend the entire 4.25-hour session, participate in the interactive polling questions and complete the post-test with a passing grade of 70% in order to be eligible for CME credit. CME certificates will become available once all components of the training are fulfilled.

For More Information and FREE training and educational resources on Medication Assisted Treatment –Providers’ Clinical Support System for Medication Assisted Treatment (PCSS-MAT) visit www.pcssnow.org.

PCSS is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in partnership with the: American Osteopathic Academy of Addiction Medicine (AOAAM); Addiction Technology Transfer Center (ATTC); American Academy of Family Physicians (AAFP); American Academy of Neurology (AAN); American Academy of Pain Medicine (AAPM); American Academy of Pediatrics (AAP); American College of Emergency Physicians (ACEP); American College of Physicians (ACP); American Dental Association (ADA); American Medical Association (AMA); American Psychiatric Association (APA); American Psychiatric Nurses Association (APNA); American Society of Addiction Medicine (ASAM); American Society for Pain Management Nursing (ASPMN); Association for Medical Education and Research in Substance Abuse (AMERSA); International Nurses Society on Addictions (IntNSA); National Association of Community Health Centers (NACHC); National Association of Drug Court Professionals (NADCP), and the Southeast Consortium for Substance Abuse Training (SECSAT). 

Funding for this initiative was made possible (in part) by grant nos. 5U79TI026556-02 and 3U79TI026556-02S1 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

May
1
Wed
Treating Pain Safer: One Hour Online Course for Safe Opioid Prescribing – AVAILABLE NOW through March 15, 2021! @ Webinar
May 1 @ 12:00 am – 12:00 am

Treating Pain Safer: One Hour Online Course for Safe Opioid Prescribing

Description:
Literature has shown that prescribers receive little education on the treatment of pain resulting in less effective pain treatment with worse outcomes. Participants will learn the evidence-based analysis of the relative effectiveness of medications and their side effects, recommendations on how to improve treatment of acute and chronic pain and recognizing substance use/opioid use disorders. Participants in this online educational activity must pass a posttest for successful completion. This course will focus on acute pain treatments/prescribing that can decrease the likelihood of long-term use.

As of July 1, 2017 all physicians (other than residents), physician assistants, nurse practitioners, podiatrists, and dentists who prescribe controlled substances must satisfy the controlled-substance prescribing CE requirement as set forth by their NC professional boards. Requirements vary by discipline and board. Prescribers will turn in controlled substance CE credits when they renew licensure.

Course Objectives:
1. Describe the impact of the opioid crisis
2. Identify the CDC guidelines for prescribing opioids for acute pain and the STOP Act
3. Discuss opioid alternatives and office policies for safe opioid prescribing

May
2
Thu
Opioid and Heroin Abuse Among Our Veterans – Online Course
May 2 @ 5:00 pm – 5:30 pm

Description: This 30-minute webinar’s purpose is to discuss how the veteran population is susceptible to the dangers of prescription opioid drug abuse.

Objectives: Discuss how opioid and heroin abuse is affecting the veteran population

Speaker: Patty L Collins, MAEd, BSN, RN, Director of Nursing CPD and Student Training

Audience: The target audience will include physicians, physician assistants, nurse practitioners, nurses, dentists, pharmacists, EMS, law enforcement, mental health professionals, substance abuse counselors, health educators, and others interested in this subject.

Available Credits: AMA PRA Category 1 Credit 0.50, CEU 1.00, ACPE 0.50, CNE Contact Hours 0.50, NCBPTE Contact Hours 0.50

Event Fees: $10.00

Opioids in the Elderly: Trends and New Guidelines – Online Course
May 2 @ 5:00 pm – 6:00 pm

Description:

This 1-hour webinar’s purpose is to discuss how the elderly population is susceptible to the dangers of prescription opioid drug abuse.

Objectives:

  • Discuss recent trends in opioid prescribing and prescription opioid misuse in the United States
  • Understand age-related changes that affect pain management
  • Describe the new opioid guidelines

Speaker:

  • Jennifer Gabbard, MD

Audience:

The target audience will include physicians, physician assistants, nurse practitioners, nurses, dentists, pharmacists, EMS, law enforcement, mental health professionals, substance abuse counselors, health educators, and others interested in this subject.

Available Credits:

  • AMA PRA Category 1 Credit 1.00
  • CEU 1.00
  • ACPE 1.00
  • CNE Contact Hours 1.00
  • NCBPTE Contact Hours 1.00

Event Fees: $10.00

May
6
Mon
Opioid and Heroin Abuse Among Our Veterans – Online Course
May 6 @ 5:00 pm – 5:30 pm

Description: This 30-minute webinar’s purpose is to discuss how the veteran population is susceptible to the dangers of prescription opioid drug abuse.

Objectives: Discuss how opioid and heroin abuse is affecting the veteran population

Speaker: Patty L Collins, MAEd, BSN, RN, Director of Nursing CPD and Student Training

Audience: The target audience will include physicians, physician assistants, nurse practitioners, nurses, dentists, pharmacists, EMS, law enforcement, mental health professionals, substance abuse counselors, health educators, and others interested in this subject.

Available Credits: AMA PRA Category 1 Credit 0.50, CEU 1.00, ACPE 0.50, CNE Contact Hours 0.50, NCBPTE Contact Hours 0.50

Event Fees: $10.00

Opioids in the Elderly: Trends and New Guidelines – Online Course
May 6 @ 5:00 pm – 6:00 pm

Description:

This 1-hour webinar’s purpose is to discuss how the elderly population is susceptible to the dangers of prescription opioid drug abuse.

Objectives:

  • Discuss recent trends in opioid prescribing and prescription opioid misuse in the United States
  • Understand age-related changes that affect pain management
  • Describe the new opioid guidelines

Speaker:

  • Jennifer Gabbard, MD

Audience:

The target audience will include physicians, physician assistants, nurse practitioners, nurses, dentists, pharmacists, EMS, law enforcement, mental health professionals, substance abuse counselors, health educators, and others interested in this subject.

Available Credits:

  • AMA PRA Category 1 Credit 1.00
  • CEU 1.00
  • ACPE 1.00
  • CNE Contact Hours 1.00
  • NCBPTE Contact Hours 1.00

Event Fees: $10.00

May
8
Wed
Analgesic Prescribing in the Opioid Overdose Epidemic: A Milligram of Prevention @ Webinar
May 8 @ 2:00 pm – 3:00 pm

Course Title: Analgesic Prescribing in the Opioid Overdose Epidemic: A Milligram of Prevention is Better than a Pound of Rehabilitation

Date and Time of Course: May 8, 2019; 2:00 PM – 3:00 PM Eastern Time

Course Description: The opioid overdose epidemic results in approximately 170 deaths every day across America. The dental profession has been responsive to the magnitude of this human tragedy and the overwhelming evidence that NSAIDs, acetaminophen and long-acting local anesthetic formulations result in greater analgesia, less adverse effects and much lower risk of drug diversion, misuse and the development of opioid use disorders. This webinar will provide greater understanding of the multiple forces that are driving this epidemic and suggest how dentists can effectively deal with the root causes of the epidemic.

Learning Objectives:

  1. Dental personnel will understand the causes that have contributed to the current opioid overdose epidemic in the US
  2. Dental prescribers will appreciate that non-opioid alternatives are more effective and can be administered to prevent acute pain and inflammation rather than attempt to manage acute pain poorly with opioids that do not  have anti-inflammatory efficacy.
  3. Dental personnel will better understand how that can contribute to minimizing the overdose crisis with patient education, evaluation of a patient’s opioid prescribing history by using the Prescription Drug Monitoring Program and how to manage an opioid overdose in the dental office.

Biosketch: Dr. Dionne is a dentist and clinical pharmacologist who conducted clinical pain research at the NIH for greater than 25 years and, in parallel, practiced general dentistry part-time in the District of Columbia. He is currently a Visiting Professor at the University of Connecticut School of Medicine and a Research Professor at the East Carolina University School of Dental Medicine.

May
11
Sat
Waiver Training Online PCSS Office-Based Treatment for Opioid Use Disorders Webinar @ Live Webcast
May 11 @ 8:00 am – 12:15 pm

As of the requirements to obtain the waiver, physicians without specified experience must complete not less than 8 hours of training. A total of 8 hours of training is federally mandated for physicians and a total of 24 hours of training is mandated for NPs and PAs.

The first half of the training is a 4.25-hour live webcast. The second half of the course is a 3.75-hour computer-based study.An examination on the computer study must be successfully completed within 30 days of the webinar session as part of the process to obtain a waiver for prescribing buprenorphine. 

Instructions on how to log on to the second half of the course will be provided via email, ONLY to those who complete the 4.25-hour live webcast in its entirety. Please note that in order to be eligible for the waiver to prescribe Buprenorphine, you must complete a total of 8 hours consisting of the live webcast session (4.25-hours) and the online self-study session and exam (3.75-hours) within 30 days of the live webcast session. The AOAAM cannot verify completion of the webinar session if less than 4.25 hours are attended. Should you not attend for the entire session, you will have to retake the entire webinar again on a different date in order to get credit. Please be aware that it is MANDATORY that you are able to view and hear the presentation and participate in the interactive polling questions in order for the AOAAM to verify your attendance. The combined live webcast and online self-study training will provide the required 8 hours needed to obtain the waiver to prescribe buprenorphine in office-based treatment of opioid dependence. Physicians who complete this course will meet the training qualification under the new law. For NPs and PAs, an additional 16-hours of training will be required for waiver eligibility.

CONTINUING MEDICAL EDUCATION: This program has been approved for 4.25 AOA Category 1-A CME credits (live webcast session only) providing all requirements have been met. It has also been approved for 4.25 AAFP Prescribed Credit hours, which are eligible for the AMA’s Physician Recognition Award Credit. Participants are required to attend the entire 4.25-hour session, participate in the interactive polling questions and complete the post-test with a passing grade of 70% in order to be eligible for CME credit. CME certificates will become available once all components of the training are fulfilled.

For More Information and FREE training and educational resources on Medication Assisted Treatment –Providers’ Clinical Support System for Medication Assisted Treatment (PCSS-MAT) visit www.pcssnow.org.

PCSS is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in partnership with the: American Osteopathic Academy of Addiction Medicine (AOAAM); Addiction Technology Transfer Center (ATTC); American Academy of Family Physicians (AAFP); American Academy of Neurology (AAN); American Academy of Pain Medicine (AAPM); American Academy of Pediatrics (AAP); American College of Emergency Physicians (ACEP); American College of Physicians (ACP); American Dental Association (ADA); American Medical Association (AMA); American Psychiatric Association (APA); American Psychiatric Nurses Association (APNA); American Society of Addiction Medicine (ASAM); American Society for Pain Management Nursing (ASPMN); Association for Medical Education and Research in Substance Abuse (AMERSA); International Nurses Society on Addictions (IntNSA); National Association of Community Health Centers (NACHC); National Association of Drug Court Professionals (NADCP), and the Southeast Consortium for Substance Abuse Training (SECSAT). 

Funding for this initiative was made possible (in part) by grant nos. 5U79TI026556-02 and 3U79TI026556-02S1 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

May
27
Mon
Waiver Training Online PCSS Office-Based Treatment for Opioid Use Disorders Webinar @ Live Webcast
May 27 @ 5:00 pm – 9:15 pm

As of the requirements to obtain the waiver, physicians without specified experience must complete not less than 8 hours of training. A total of 8 hours of training is federally mandated for physicians and a total of 24 hours of training is mandated for NPs and PAs.

The first half of the training is a 4.25-hour live webcast. The second half of the course is a 3.75-hour computer-based study. An examination on the computer study must be successfully completed within 30 days of the webinar session as part of the process to obtain a waiver for prescribing buprenorphine. 

Instructions on how to log on to the second half of the course will be provided via email, ONLY to those who complete the 4.25-hour live webcast in its entirety. Please note that in order to be eligible for the waiver to prescribe Buprenorphine, you must complete a total of 8 hours consisting of the live webcast session (4.25-hours) and the online self-study session and exam (3.75-hours) within 30 days of the live webcast session. The AOAAM cannot verify completion of the webinar session if less than 4.25 hours are attended. Should you not attend for the entire session, you will have to retake the entire webinar again on a different date in order to get credit. Please be aware that it is MANDATORY that you are able to view and hear the presentation and participate in the interactive polling questions in order for the AOAAM to verify your attendance. The combined live webcast and online self-study training will provide the required 8 hours needed to obtain the waiver to prescribe buprenorphine in office-based treatment of opioid dependence. Physicians who complete this course will meet the training qualification under the new law. For NPs and PAs, an additional 16-hours of training will be required for waiver eligibility.

CONTINUING MEDICAL EDUCATION: This program has been approved for 4.25 AOA Category 1-A CME credits (live webcast session only) providing all requirements have been met. It has also been approved for 4.25 AAFP Prescribed Credit hours, which are eligible for the AMA’s Physician Recognition Award Credit. Participants are required to attend the entire 4.25-hour session, participate in the interactive polling questions and complete the post-test with a passing grade of 70% in order to be eligible for CME credit. CME certificates will become available once all components of the training are fulfilled.

For More Information and FREE training and educational resources on Medication Assisted Treatment –Providers’ Clinical Support System for Medication Assisted Treatment (PCSS-MAT) visit www.pcssnow.org.

PCSS is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in partnership with the: American Osteopathic Academy of Addiction Medicine (AOAAM); Addiction Technology Transfer Center (ATTC); American Academy of Family Physicians (AAFP); American Academy of Neurology (AAN); American Academy of Pain Medicine (AAPM); American Academy of Pediatrics (AAP); American College of Emergency Physicians (ACEP); American College of Physicians (ACP); American Dental Association (ADA); American Medical Association (AMA); American Psychiatric Association (APA); American Psychiatric Nurses Association (APNA); American Society of Addiction Medicine (ASAM); American Society for Pain Management Nursing (ASPMN); Association for Medical Education and Research in Substance Abuse (AMERSA); International Nurses Society on Addictions (IntNSA); National Association of Community Health Centers (NACHC); National Association of Drug Court Professionals (NADCP), and the Southeast Consortium for Substance Abuse Training (SECSAT). 

Funding for this initiative was made possible (in part) by grant nos. 5U79TI026556-02 and 3U79TI026556-02S1 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

May
28
Tue
Vaccines for Opioid Use Disorder: Focusing on the Fentanyl Epidemic @ Webinar
May 28 @ 12:00 pm – 1:00 pm

Presenter(s): Thomas R. Kosten, MD, Waggoner Professor in Psychiatry, Pharmacology, Neuroscience, Baylor College of Medicine; Fang Yang, MD, PhD, Addiction Psychiatry Fellow, Baylor College of Medicine

Target Audience: This activity was developed to meet the needs of psychiatric clinicians (medical doctors, psychiatric nurses).

Webinar description: Fentanyl is the leading cause of opioid overdoses during the last couple of years, and these overdoses are not prevented by methadone, buprenorphine or naltrexone treatment. However, a vaccine against fentanyl has been able to block fentanyl’s analgesic, reinforcing and respiratory depressant effects in animal models. This vaccine is moving toward FDA approval to be tested in humans.

Educational objectives:

  • Identify the extent and greatest geographic concentration of fentanyl overdoses and abuse in the current USA opioid epidemic.
  • Define how and why current treatments with naltrexone, methadone and buprenorphine are ineffective for fentanyl abuse.
  • Identify the mechanism of action for fentanyl vaccines in preventing overdoses and abuse through the production of anti-fentanyl antibodies.

Accreditation:
The American Psychiatric Association (APA) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation:
American Psychiatric Association (APA) designates this live activity for a maximum of 1 (one) AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

May
29
Wed
Webinar: Evidence-Based Strategies for Preventing Opioid Overdose @ Webinar
May 29 @ 12:00 pm – 1:30 pm
In September 2018, the Centers for Disease Control and Prevention (CDC) released “Evidence-Based Strategies for Preventing Opioid Overdose: What’s Working in the United States.” On behalf of the National Center for Injury Prevention and Control of the Centers for Disease Control and Prevention and the Center for Faith and Opportunity Initiatives at the U.S. Department of Health and Human Services, we invite you to join us for a discussion on implementing these strategies for preventing opioid overdose in local communities. Community level presenters engaged in programs for harm reduction, treatment initiation and provider education will discuss their work and efforts to successfully implement their program.

Webinar: Evidence-Based Strategies for Preventing Opioid Overdose

When: May 29, 2019 from 12:00-1:30PM EDT

Call-in Access: 1-929-205-6099

Webinar ID: 226-961-046

 

Presenters:

Amber Robinson, PhD, Centers for Disease Control and Prevention, GA

Alice Bell, LCSW, Prevention Point Pittsburgh, PA

Haley Coles, Sonoran Prevention Works, AZ

Nick Jensen, MPA, Shot in the Dark and Sonoran Prevention Works, AZ

Sarah Wakeman, MD, Mass General Hospital, MA

Jun
1
Sat
Treating Pain Safer: One Hour Online Course for Safe Opioid Prescribing – AVAILABLE NOW through March 15, 2021! @ Webinar
Jun 1 @ 12:00 am – 12:00 am

Treating Pain Safer: One Hour Online Course for Safe Opioid Prescribing

Description:
Literature has shown that prescribers receive little education on the treatment of pain resulting in less effective pain treatment with worse outcomes. Participants will learn the evidence-based analysis of the relative effectiveness of medications and their side effects, recommendations on how to improve treatment of acute and chronic pain and recognizing substance use/opioid use disorders. Participants in this online educational activity must pass a posttest for successful completion. This course will focus on acute pain treatments/prescribing that can decrease the likelihood of long-term use.

As of July 1, 2017 all physicians (other than residents), physician assistants, nurse practitioners, podiatrists, and dentists who prescribe controlled substances must satisfy the controlled-substance prescribing CE requirement as set forth by their NC professional boards. Requirements vary by discipline and board. Prescribers will turn in controlled substance CE credits when they renew licensure.

Course Objectives:
1. Describe the impact of the opioid crisis
2. Identify the CDC guidelines for prescribing opioids for acute pain and the STOP Act
3. Discuss opioid alternatives and office policies for safe opioid prescribing

Jun
3
Mon
Opioid and Heroin Abuse Among Our Veterans – Online Course
Jun 3 @ 5:00 pm – 5:30 pm

Description: This 30-minute webinar’s purpose is to discuss how the veteran population is susceptible to the dangers of prescription opioid drug abuse.

Objectives: Discuss how opioid and heroin abuse is affecting the veteran population

Speaker: Patty L Collins, MAEd, BSN, RN, Director of Nursing CPD and Student Training

Audience: The target audience will include physicians, physician assistants, nurse practitioners, nurses, dentists, pharmacists, EMS, law enforcement, mental health professionals, substance abuse counselors, health educators, and others interested in this subject.

Available Credits: AMA PRA Category 1 Credit 0.50, CEU 1.00, ACPE 0.50, CNE Contact Hours 0.50, NCBPTE Contact Hours 0.50

Event Fees: $10.00

Opioids in the Elderly: Trends and New Guidelines – Online Course
Jun 3 @ 5:00 pm – 6:00 pm

Description:

This 1-hour webinar’s purpose is to discuss how the elderly population is susceptible to the dangers of prescription opioid drug abuse.

Objectives:

  • Discuss recent trends in opioid prescribing and prescription opioid misuse in the United States
  • Understand age-related changes that affect pain management
  • Describe the new opioid guidelines

Speaker:

  • Jennifer Gabbard, MD

Audience:

The target audience will include physicians, physician assistants, nurse practitioners, nurses, dentists, pharmacists, EMS, law enforcement, mental health professionals, substance abuse counselors, health educators, and others interested in this subject.

Available Credits:

  • AMA PRA Category 1 Credit 1.00
  • CEU 1.00
  • ACPE 1.00
  • CNE Contact Hours 1.00
  • NCBPTE Contact Hours 1.00

Event Fees: $10.00

Jun
8
Sat
Waiver Training Online PCSS Office-Based Treatment for Opioid Use Disorders Webinar @ Live Webcast
Jun 8 @ 8:00 am – 12:15 pm

As of the requirements to obtain the waiver, physicians without specified experience must complete not less than 8 hours of training. A total of 8 hours of training is federally mandated for physicians and a total of 24 hours of training is mandated for NPs and PAs.

The first half of the training is a 4.25-hour live webcast. The second half of the course is a 3.75-hour computer-based study.An examination on the computer study must be successfully completed within 30 days of the webinar session as part of the process to obtain a waiver for prescribing buprenorphine. 

Instructions on how to log on to the second half of the course will be provided via email, ONLY to those who complete the 4.25-hour live webcast in its entirety. Please note that in order to be eligible for the waiver to prescribe Buprenorphine, you must complete a total of 8 hours consisting of the live webcast session (4.25-hours) and the online self-study session and exam (3.75-hours) within 30 days of the live webcast session. The AOAAM cannot verify completion of the webinar session if less than 4.25 hours are attended. Should you not attend for the entire session, you will have to retake the entire webinar again on a different date in order to get credit. Please be aware that it is MANDATORY that you are able to view and hear the presentation and participate in the interactive polling questions in order for the AOAAM to verify your attendance. The combined live webcast and online self-study training will provide the required 8 hours needed to obtain the waiver to prescribe buprenorphine in office-based treatment of opioid dependence. Physicians who complete this course will meet the training qualification under the new law. For NPs and PAs, an additional 16-hours of training will be required for waiver eligibility.

CONTINUING MEDICAL EDUCATION: This program has been approved for 4.25 AOA Category 1-A CME credits (live webcast session only) providing all requirements have been met. It has also been approved for 4.25 AAFP Prescribed Credit hours, which are eligible for the AMA’s Physician Recognition Award Credit. Participants are required to attend the entire 4.25-hour session, participate in the interactive polling questions and complete the post-test with a passing grade of 70% in order to be eligible for CME credit. CME certificates will become available once all components of the training are fulfilled.

For More Information and FREE training and educational resources on Medication Assisted Treatment –Providers’ Clinical Support System for Medication Assisted Treatment (PCSS-MAT) visit www.pcssnow.org.

PCSS is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in partnership with the: American Osteopathic Academy of Addiction Medicine (AOAAM); Addiction Technology Transfer Center (ATTC); American Academy of Family Physicians (AAFP); American Academy of Neurology (AAN); American Academy of Pain Medicine (AAPM); American Academy of Pediatrics (AAP); American College of Emergency Physicians (ACEP); American College of Physicians (ACP); American Dental Association (ADA); American Medical Association (AMA); American Psychiatric Association (APA); American Psychiatric Nurses Association (APNA); American Society of Addiction Medicine (ASAM); American Society for Pain Management Nursing (ASPMN); Association for Medical Education and Research in Substance Abuse (AMERSA); International Nurses Society on Addictions (IntNSA); National Association of Community Health Centers (NACHC); National Association of Drug Court Professionals (NADCP), and the Southeast Consortium for Substance Abuse Training (SECSAT). 

Funding for this initiative was made possible (in part) by grant nos. 5U79TI026556-02 and 3U79TI026556-02S1 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.